BRIELLYN (Glenmark Pharmaceuticals Inc., USA)
Welcome to the PulseAid listing for the BRIELLYN drug offered from Glenmark Pharmaceuticals Inc., USA. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Glenmark Pharmaceuticals Inc., USA |
| NON-PROPRIETARY NAME: | Norethindrone and Ethinyl Estradiol |
| SUBSTANCE NAME: | |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2011-03-23 |
| END MARKETING DATE: | 0000-00-00 |
BRIELLYN HUMAN PRESCRIPTION DRUG Details:
| Item Description | BRIELLYN from Glenmark Pharmaceuticals Inc., USA |
| LABELER NAME: | Glenmark Pharmaceuticals Inc., USA |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2011-03-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68462-316_f1eb85b8-6a52-44fc-803d-84599ccc792a |
| PRODUCT NDC: | 68462-316 |
| APPLICATION NUMBER: | ANDA090538 |